Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: ENOV )

45.00 -0.02 (-0.04%)
Official Closing Price Updated: 7:00 PM EDT, Jun 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 877,967
Open 44.81
Bid (Size) 43.99 (1)
Ask (Size) 45.98 (1)
Prev. Close 45.02
Today's Range 44.43 - 45.05
52wk Range 43.04 - 66.14
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 3 Health Care Stocks That Could Blast Off In June
Via Benzinga
5 Medical Info Systems Stocks To Buy For Stable Returns
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024. 
Via Talk Markets

Performance

YTD
-18.83%
-18.83%
1 Month
-9.49%
-9.49%
3 Month
-25.35%
-25.35%
6 Month
-20.86%
-20.86%
1 Year
-26.83%
-26.83%

More News

Read More
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
A Closer Look at 6 Analyst Recommendations For Enovis
Via Benzinga
Earnings Outlook For Enovis
Via Benzinga
5 Analysts Have This To Say About Enovis
Via Benzinga
The Analyst Landscape: 6 Takes On Enovis
Via Benzinga
Analyst Ratings for Enovis
Via Benzinga
ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Enovis Announces First Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
Via Benzinga
Topics Earnings
Exposures Financial
Enovis Announces Fourth Quarter and Full Year 2023 Results
From Enovis Corporation
Via GlobeNewswire
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
From Enovis Corporation
Via GlobeNewswire
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
From Enovis Corporation
Via GlobeNewswire
Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
From Enovis Corporation
Via GlobeNewswire
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
From Enovis Corporation
Via GlobeNewswire
This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis
Via Benzinga
Enovis Completes Acquisition of LimaCorporate S.p.A
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
Via Benzinga
Enovis Announces Business Segment Leadership Transition Plan
From Enovis Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.